What is Sublocade? Sublocade ™ is the trademark for a new monthly injection of buprenorphine (the active drug in Suboxone). The FDA approved this injectable extended-release buprenorphine drug, in 2017, as a schedule III-controlled substance for the treatment of moderate to severe OUD (Opioid Use Disorder). Before Sublocade ™ was introduced, buprenorphine drugs were typically […]
Fentanyl is a powerful opioid drug available in transdermal patches (Duragesic), as a lozenge (Aqtic), or as an injectable (Sublimaze). Although this medication has a similar mechanism of action to heroin, it is much more potent. NIDA reports it to be 50 to 100 times more powerful than morphine, making fentanyl withdrawal incredibly challenging to […]
Drug dependency can feel like an impossible challenge—and it’s a challenge that indeed doesn’t discriminate. Opioid addiction affects people at all points on the socioeconomic scale, from the smallest and most impoverished communities to the most well-off. It’s not hard to imagine how a financially affluent background affords a person better resources to treat opioid […]
How is it that nearly one in three people know someone who is or was suffering from opioid addiction, yet the current model of intervention for such a common problem is so ineffective? Why are people still allowed to suffer unnecessarily while putting their well-being at dire risk as they await appropriate opioid use disorder […]
